Sophie Adlard has joined J+D Consulting as a business analyst. Sophie’s focus over the last few years has been in biochemistry, and included oncology drug therapy development for one of the top 10 pharma companies in the world.
New hire for J+D Consulting
- Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection
- Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
- New NIHR HRC launched for cardiovascular and respiratory medicine
- Study links dementia antipsychotics to higher risks of serious health outcomes
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
